Capital International LTD Eli Lilly & CO Transaction History

Capital International LTD

$2.09 Billion
Q2 2024

A detailed history of Capital International LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital International LTD holds 67,938 shares of LLY stock, worth $62 Million. This represents 2.94% of its overall portfolio holdings.

Number of Shares

67,938

Previous 72,463 6.24%

Holding current value

$62 Million

Previous $56.4 Million 9.11%

% of portfolio

2.94%

Previous 2.81%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $3.28 Million - $4.11 Million	-4,525 Reduced 6.24%	67,938 $61.5 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $16.3 Million - $21.8 Million	-27,522 Reduced 27.53%	72,463 $56.4 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $1.1 Million - $1.3 Million	-2,100 Reduced 2.06%	99,985 $58.3 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $11,302 - $15,581	-26 Reduced 0.03%	102,085 $54.8 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $1.51 Million - $2.02 Million	-4,304 Reduced 4.04%	102,111 $47.9 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $116,796 - $137,172	376 Added 0.35%	106,415 $36.5 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $263,027 - $306,480	818 Added 0.78%	106,039 $38.8 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $1.53 Million - $1.74 Million	5,159 Added 5.16%	105,221 $34 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $14.1 Million - $16.6 Million	50,586 Added 102.24%	100,062 $32.4 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $3.54 Million - $4.4 Million	15,084 Added 43.86%	49,476 $14.2 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $1.43 Million - $1.77 Million	6,355 Added 22.67%	34,392 $9.5 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $71,798 - $88,358	-324 Reduced 1.14%	28,037 $6.48 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $11,013 - $14,245	61 Added 0.22%	28,361 $6.51 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $4.65 Million - $6.02 Million	28,300 New	28,300 $5.29 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $1.18 Million - $1.56 Million	-9,025 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $21,786 - $25,200	149 Added 1.68%	9,025 $1.34 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $1.71 Million - $2.06 Million	-12,517 Reduced 58.51%	8,876 $1.46 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $836,207 - $1.03 Million	-7,024 Reduced 24.72%	21,393 $2.97 Million
Q4 2019 Feb 18, 2020	SELL	$106.92 - $132.43 $1.7 Million - $2.1 Million	-15,866 Reduced 35.83%	28,417 $3.74 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $353,154 - $384,141	3,307 Added 8.07%	44,283 $4.95 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $285,173 - $332,869	-2,574 Reduced 5.91%	40,976 $4.54 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $100,179 - $117,918	900 Added 2.11%	43,550 $5.65 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $2.86 Million - $3.2 Million	27,000 Added 172.52%	42,650 $4.94 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $752,562 - $940,572	-8,765 Reduced 35.9%	15,650 $1.68 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $22,710 - $26,064	-300 Reduced 1.21%	24,415 $2.08 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $98,179 - $115,894	1,323 Added 5.66%	24,715 $1.91 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $767,368 - $823,089	-9,365 Reduced 28.59%	23,392 $1.98 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $2.52 Million - $2.8 Million	32,757	32,757 $2.8 Million

Others Institutions Holding LLY

# of Institutions

3,865

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $867B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

News

Stay updated on Capital International LTD with notifications on news.

Account

Capital International LTD Eli Lilly & CO Transaction History